Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Laphonza Butler

Butler’s cash, Mucarsel-Powell’s post-Congress life and Rogers’ lineup

Ever wonder what the head of EMILY’s List earns each year? Sen. Laphonza Butler (D-Calif.) just filed her financial disclosure form, and she made $700,000 from serving as president of the group.

Butler, who California Gov. Gavin Newsom appointed to fill the late Democratic Sen. Dianne Feinstein’s seat, is not running for election in 2024.

Former Rep. Debbie Mucarsel-Powell (D-Fla.), who is running against Sen. Rick Scott (R-Fla.), reported she made $479,554 in 2022 and 2023 — after she lost her seat in the House. Mucarsel-Powell reported consulting work for the Roseman University of Health Sciences in Nevada, Third Way and served as a fellow at the George Washington University. She was also paid $3,900 for appearing on Telemundo.

Former Rep. Mike Rogers (R-Mich.), who is running for the nomination to take on Rep. Elissa Slotkin (D-Mich.) for the Senate, has racked up a long lineup of board seats and consulting clients. For example, Rogers reported having made $460,000 from Nokia, $191,056 from the Mitre Corporation, $137,000 from IAP Worldwide Services and $724,887 from IronNet Cybersecurity.

Presented by Pharmaceutical Reform Alliance

Americans know who to blame for rising drug prices: Big Pharma. A majority of Republicans, Democrats, & Independents all believe Big Pharma’s focus on profits keeps drug prices high. Let’s hold Big Pharma accountable – it’s an issue we’re united on.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.